Virus Expression Database
Submitted by Emanuel Wyler (Max Delbrück Center for Molecular Medicine, Germany) on Jan 15 2021
Platform: ngs – Illumina NextSeq 500 (Homo sapiens)
Pubmed: 33585804
Summary To identify human genes and cellular pathways influencing SARS-CoV-1 and SARS-CoV-2 infection, we performed genome-wide measurements of different aspects of gene expression at the bulk and single-cell level.
| ID | Title | Cell Type | Timepoint | Reported Virus | Virus Species | Exclusion Reason |
|---|---|---|---|---|---|---|
| GSM4477854 | H1299_polyA_mock-36h-A | non-small cell lung cancer cell line  [NCI-H1299  ] |
Mock | Uninfected | ||
| GSM4477855 | H1299_polyA_mock-36h-B | non-small cell lung cancer cell line [NCI-H1299 ] |
Mock | Uninfected | ||
| GSM4477856 | H1299_polyA_mock-4h-A | non-small cell lung cancer cell line [NCI-H1299 ] |
Mock | Uninfected | ||
| GSM4477857 | H1299_polyA_mock-4h-B | non-small cell lung cancer cell line [NCI-H1299 ] |
Mock | Uninfected | ||
| GSM4477858 | H1299_polyA_S1-12h-A | non-small cell lung cancer cell line [NCI-H1299 ] |
12 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477859 | H1299_polyA_S1-12h-B | non-small cell lung cancer cell line [NCI-H1299 ] |
12 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477860 | H1299_polyA_S1-24h-A | non-small cell lung cancer cell line [NCI-H1299 ] |
24 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477861 | H1299_polyA_S1-24h-B | non-small cell lung cancer cell line [NCI-H1299 ] |
24 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477862 | H1299_polyA_S1-36h-A | non-small cell lung cancer cell line [NCI-H1299 ] |
36 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477863 | H1299_polyA_S1-36h-B | non-small cell lung cancer cell line [NCI-H1299 ] |
36 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477864 | H1299_polyA_S1-4h-A | non-small cell lung cancer cell line [NCI-H1299 ] |
4 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477865 | H1299_polyA_S1-4h-B | non-small cell lung cancer cell line [NCI-H1299 ] |
4 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477866 | H1299_polyA_S2-12h-A | non-small cell lung cancer cell line [NCI-H1299 ] |
12 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477867 | H1299_polyA_S2-12h-B | non-small cell lung cancer cell line [NCI-H1299 ] |
12 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477868 | H1299_polyA_S2-24h-A | non-small cell lung cancer cell line [NCI-H1299 ] |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477869 | H1299_polyA_S2-24h-B | non-small cell lung cancer cell line [NCI-H1299 ] |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477870 | H1299_polyA_S2-36h-A | non-small cell lung cancer cell line [NCI-H1299 ] |
36 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477871 | H1299_polyA_S2-36h-B | non-small cell lung cancer cell line [NCI-H1299 ] |
36 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477872 | H1299_polyA_S2-4h-A | non-small cell lung cancer cell line [NCI-H1299 ] |
4 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477873 | H1299_polyA_S2-4h-B | non-small cell lung cancer cell line [NCI-H1299 ] |
4 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477874 | H1299_polyA_untr-4h-A | non-small cell lung cancer cell line [NCI-H1299 ] |
untreated | Uninfected | ||
| GSM4477875 | H1299_polyA_untr-4h-B | non-small cell lung cancer cell line [NCI-H1299 ] |
untreated | Uninfected | ||
| GSM4477876 | Caco2_polyA-mock-24h-A | colonic adenocarcinoma cell line [Caco-2 ] |
Mock | Uninfected | ||
| GSM4477877 | Caco2_polyA-mock-24h-B | colonic adenocarcinoma cell line [Caco-2 ] |
Mock | Uninfected | ||
| GSM4477878 | Caco2_polyA-mock-4h-A | colonic adenocarcinoma cell line [Caco-2 ] |
Mock | Uninfected | ||
| GSM4477879 | Caco2_polyA-mock-4h-B | colonic adenocarcinoma cell line [Caco-2 ] |
Mock | Uninfected | ||
| GSM4477880 | Caco2_polyA-S1-12h-A | colonic adenocarcinoma cell line [Caco-2 ] |
12 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477881 | Caco2_polyA-S1-12h-B | colonic adenocarcinoma cell line [Caco-2 ] |
12 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477882 | Caco2_polyA-S1-24h-A | colonic adenocarcinoma cell line [Caco-2 ] |
24 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477883 | Caco2_polyA-S1-24h-B | colonic adenocarcinoma cell line [Caco-2 ] |
24 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477884 | Caco2_polyA-S1-4h-A | colonic adenocarcinoma cell line [Caco-2 ] |
4 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477885 | Caco2_polyA-S1-4h-B | colonic adenocarcinoma cell line [Caco-2 ] |
4 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477886 | Caco2_polyA-S2-12h-A | colonic adenocarcinoma cell line [Caco-2 ] |
12 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477887 | Caco2_polyA-S2-12h-B | colonic adenocarcinoma cell line [Caco-2 ] |
12 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477888 | Caco2_polyA-S2-24h-A | colonic adenocarcinoma cell line [Caco-2 ] |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477889 | Caco2_polyA-S2-24h-B | colonic adenocarcinoma cell line [Caco-2 ] |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477890 | Caco2_polyA-S2-4h-A | colonic adenocarcinoma cell line [Caco-2 ] |
4 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477891 | Caco2_polyA-S2-4h-B | colonic adenocarcinoma cell line [Caco-2 ] |
4 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477892 | Caco2_polyA-untr-4h-A | colonic adenocarcinoma cell line [Caco-2 ] |
untreated | Uninfected | ||
| GSM4477893 | Caco2_polyA-untr-4h-B | colonic adenocarcinoma cell line [Caco-2 ] |
untreated | Uninfected | ||
| GSM4477894 | Calu3_polyA_series1-untr-4h-A | lung adenocarcinoma cell line [Calu-3 ] |
untreated | Uninfected | ||
| GSM4477895 | Calu3_polyA_series1-untr-4h-B | lung adenocarcinoma cell line [Calu-3 ] |
untreated | Uninfected | ||
| GSM4477896 | Calu3_polyA_series1-mock-4h-A | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4477897 | Calu3_polyA_series1-mock-4h-B | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4477898 | Calu3_polyA_series1-mock-24h-A | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4477899 | Calu3_polyA_series1-mock-24h-B | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4477900 | Calu3_polyA_series1-S1-4h-A | lung adenocarcinoma cell line [Calu-3 ] |
4 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477901 | Calu3_polyA_series1-S1-4h-B | lung adenocarcinoma cell line [Calu-3 ] |
4 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477902 | Calu3_polyA_series1-S1-12h-A | lung adenocarcinoma cell line [Calu-3 ] |
12 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477903 | Calu3_polyA_series1-S1-12h-B | lung adenocarcinoma cell line [Calu-3 ] |
12 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477904 | Calu3_polyA_series1-S1-24h-A | lung adenocarcinoma cell line [Calu-3 ] |
24 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477905 | Calu3_polyA_series1-S1-24h-B | lung adenocarcinoma cell line [Calu-3 ] |
24 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477906 | Calu3_polyA_series1-S2-4h-A | lung adenocarcinoma cell line [Calu-3 ] |
4 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477907 | Calu3_polyA_series1-S2-4h-B | lung adenocarcinoma cell line [Calu-3 ] |
4 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477908 | Calu3_polyA_series1-S2-12h-A | lung adenocarcinoma cell line [Calu-3 ] |
12 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477909 | Calu3_polyA_series1-S2-12h-B | lung adenocarcinoma cell line [Calu-3 ] |
12 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477910 | Calu3_polyA_series1-S2-24h-A | lung adenocarcinoma cell line [Calu-3 ] |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477911 | Calu3_polyA_series1-S2-24h-B | lung adenocarcinoma cell line [Calu-3 ] |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477912 | Calu3_polyA_series1-S1-24h-A-detachedcells | lung adenocarcinoma cell line [Calu-3 ] |
24 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477913 | Calu3_polyA_series1-S1-24h-B-detachedcells | lung adenocarcinoma cell line [Calu-3 ] |
24 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477914 | Calu3_polyA_series1-S2-24h-A-detachedcells | lung adenocarcinoma cell line [Calu-3 ] |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Data failed QCpseudoaligned_reads is 1256245 (low number of usable reads) |
| GSM4477915 | Calu3_polyA_series1-S2-24h-B-detachedcells | lung adenocarcinoma cell line [Calu-3 ] |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Data failed QCpseudoaligned_reads is 1287922 (low number of usable reads) |
| GSM4477916 | Calu3_polyA_series2-12h-mock-1 | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4477917 | Calu3_polyA_series2-12h-mock-2 | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4477918 | Calu3_polyA_series2-12h-S1-1 | lung adenocarcinoma cell line [Calu-3 ] |
12 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477919 | Calu3_polyA_series2-12h-S1-2 | lung adenocarcinoma cell line [Calu-3 ] |
12 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477920 | Calu3_polyA_series2-12h-S2-1 | lung adenocarcinoma cell line [Calu-3 ] |
12 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477921 | Calu3_polyA_series2-12h-S2-2 | lung adenocarcinoma cell line [Calu-3 ] |
12 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477922 | Calu3_polyA_series2-4h-mock-1 | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4477923 | Calu3_polyA_series2-4h-mock-2 | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4477924 | Calu3_polyA_series2-4h-S1-1 | lung adenocarcinoma cell line [Calu-3 ] |
4 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477925 | Calu3_polyA_series2-4h-S1-2 | lung adenocarcinoma cell line [Calu-3 ] |
4 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477926 | Calu3_polyA_series2-4h-S2-1 | lung adenocarcinoma cell line [Calu-3 ] |
4 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477927 | Calu3_polyA_series2-4h-S2-2 | lung adenocarcinoma cell line [Calu-3 ] |
4 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477928 | Calu3_polyA_series2-8h-S1-1 | lung adenocarcinoma cell line [Calu-3 ] |
8 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477929 | Calu3_polyA_series2-8h-S1-2 | lung adenocarcinoma cell line [Calu-3 ] |
8 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477930 | Calu3_polyA_series2-8h-S2-1 | lung adenocarcinoma cell line [Calu-3 ] |
8 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477931 | Calu3_polyA_series2-8h-S2-2 | lung adenocarcinoma cell line [Calu-3 ] |
8 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477932 | Calu3_smallRNA-mock-24h-A | Wrong technology small RNA seq |
||||
| GSM4477933 | Calu3_smallRNA-mock-24h-B | Wrong technology small RNA seq |
||||
| GSM4477934 | Calu3_smallRNA-mock-4h-A | Wrong technology small RNA seq |
||||
| GSM4477935 | Calu3_smallRNA-mock-4h-B | Wrong technology small RNA seq |
||||
| GSM4477936 | Calu3_smallRNA-S1-12h-A | Wrong technology small RNA seq |
||||
| GSM4477937 | Calu3_smallRNA-S1-12h-B | Wrong technology small RNA seq |
||||
| GSM4477938 | Calu3_smallRNA-S1-24h-A | Wrong technology small RNA seq |
||||
| GSM4477939 | Calu3_smallRNA-S1-24h-B | Wrong technology small RNA seq |
||||
| GSM4477940 | Calu3_smallRNA-S1-4h-A | Wrong technology small RNA seq |
||||
| GSM4477941 | Calu3_smallRNA-S1-4h-B | Wrong technology small RNA seq |
||||
| GSM4477942 | Calu3_smallRNA-S2-12h-A | Wrong technology small RNA seq |
||||
| GSM4477943 | Calu3_smallRNA-S2-12h-B | Wrong technology small RNA seq |
||||
| GSM4477944 | Calu3_smallRNA-S2-24h-A | Wrong technology small RNA seq |
||||
| GSM4477945 | Calu3_smallRNA-S2-24h-B | Wrong technology small RNA seq |
||||
| GSM4477946 | Calu3_smallRNA-S2-4h-A | Wrong technology small RNA seq |
||||
| GSM4477947 | Calu3_smallRNA-S2-4h-B | Wrong technology small RNA seq |
||||
| GSM4477948 | Calu3_smallRNA-untr-4h-A | Wrong technology small RNA seq |
||||
| GSM4477949 | Calu3_smallRNA-untr-4h-B | Wrong technology small RNA seq |
||||
| GSM4477950 | Calu3_totalRNA-mock-24h-A | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4477951 | Calu3_totalRNA-mock-24h-B | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4477952 | Calu3_totalRNA-mock-4h-A | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4477953 | Calu3_totalRNA-mock-4h-B | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4477954 | Calu3_totalRNA-S1-12h-A | lung adenocarcinoma cell line [Calu-3 ] |
12 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477955 | Calu3_totalRNA-S1-12h-B | lung adenocarcinoma cell line [Calu-3 ] |
12 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477956 | Calu3_totalRNA-S1-24h-A | lung adenocarcinoma cell line [Calu-3 ] |
24 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | Data failed QCpct_pseudoaligned is 14.3% (low fraction of usable reads) |
| GSM4477957 | Calu3_totalRNA-S1-24h-B | lung adenocarcinoma cell line [Calu-3 ] |
24 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | Data failed QCpct_pseudoaligned is 14.5% (low fraction of usable reads) |
| GSM4477958 | Calu3_totalRNA-S1-4h-A | lung adenocarcinoma cell line [Calu-3 ] |
4 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477959 | Calu3_totalRNA-S1-4h-B | lung adenocarcinoma cell line [Calu-3 ] |
4 hrs | SARS-CoV-1 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477960 | Calu3_totalRNA-S2-12h-A | lung adenocarcinoma cell line [Calu-3 ] |
12 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477961 | Calu3_totalRNA-S2-12h-B | lung adenocarcinoma cell line [Calu-3 ] |
12 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477962 | Calu3_totalRNA-S2-24h-A | lung adenocarcinoma cell line [Calu-3 ] |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477963 | Calu3_totalRNA-S2-24h-B | lung adenocarcinoma cell line [Calu-3 ] |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477964 | Calu3_totalRNA-S2-4h-A | lung adenocarcinoma cell line [Calu-3 ] |
4 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477965 | Calu3_totalRNA-S2-4h-B | lung adenocarcinoma cell line [Calu-3 ] |
4 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4477966 | Calu3_totalRNA-untr-4h-A | lung adenocarcinoma cell line [Calu-3 ] |
untreated | Uninfected | ||
| GSM4477967 | Calu3_totalRNA-untr-4h-B | lung adenocarcinoma cell line [Calu-3 ] |
untreated | Uninfected | ||
| GSM4477968 | H1299_scRNAseq-mock-36h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477969 | H1299_scRNAseq-mock-36h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477970 | H1299_scRNAseq-mock-4h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477971 | H1299_scRNAseq-mock-4h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477972 | H1299_scRNAseq-S1-12h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477973 | H1299_scRNAseq-S1-12h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477974 | H1299_scRNAseq-S1-24h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477975 | H1299_scRNAseq-S1-24h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477976 | H1299_scRNAseq-S1-36h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477977 | H1299_scRNAseq-S1-36h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477978 | H1299_scRNAseq-S2-12h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477979 | H1299_scRNAseq-S2-12h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477980 | H1299_scRNAseq-S2-24h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477981 | H1299_scRNAseq-S2-24h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477982 | H1299_scRNAseq-S2-36h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477983 | H1299_scRNAseq-S2-36h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477984 | Calu3_scRNAseq-mock-12h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477985 | Calu3_scRNAseq-mock-12h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477986 | Calu3_scRNAseq-mock-4h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477987 | Calu3_scRNAseq-mock-4h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477988 | Calu3_scRNAseq-S1-12h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477989 | Calu3_scRNAseq-S1-12h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477990 | Calu3_scRNAseq-S1-4h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477991 | Calu3_scRNAseq-S1-4h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477992 | Calu3_scRNAseq-S1-8h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477993 | Calu3_scRNAseq-S1-8h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477994 | Calu3_scRNAseq-S2-12h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477995 | Calu3_scRNAseq-S2-12h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477996 | Calu3_scRNAseq-S2-4h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477997 | Calu3_scRNAseq-S2-4h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4477998 | Calu3_scRNAseq-S2-8h-A | Wrong technology single-cell RNA-Seq |
||||
| GSM4477999 | Calu3_scRNAseq-S2-8h-B | Wrong technology single-cell RNA-Seq |
||||
| GSM4681394 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 1 , DMSO treated, mock infected, replicate 1 | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4681395 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 1 , DMSO treated, mock infected, replicate 2 | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4681396 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 1 , DMSO treated, mock infected, replicate 3 | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4681397 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 1 , DMSO treated, S2 infected, replicate 1 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4681398 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 1 , DMSO treated, S2 infected, replicate 2 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4681399 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 1 , DMSO treated, S2 infected, replicate 3 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4681400 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 1 , 800 nM Onalespib treated, S2 infected, replicate 1 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions Onalespib treated |
| GSM4681401 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 1 , 800 nM Onalespib treated, S2 infected, replicate 2 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions Onalespib treated |
| GSM4681402 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 1 , 800 nM Onalespib treated, S2 infected, replicate 3 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions Onalespib treated |
| GSM4681403 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 2 , DMSO treated, mock infected, replicate 1 | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4681404 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 2 , DMSO treated, mock infected, replicate 2 | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4681405 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 2 , DMSO treated, mock infected, replicate 3 | lung adenocarcinoma cell line [Calu-3 ] |
Mock | Uninfected | ||
| GSM4681406 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 2 , DMSO treated, S2 infected, replicate 1 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4681407 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 2 , DMSO treated, S2 infected, replicate 2 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4681408 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 2 , DMSO treated, S2 infected, replicate 3 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | |
| GSM4681409 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 2 , 800 nM 17-AAG treated, S2 infected, replicate 1 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions 17-AAG treated |
| GSM4681410 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 2 , 800 nM 17-AAG treated, S2 infected, replicate 2 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions 17-AAG treated |
| GSM4681411 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 2 , 800 nM 17-AAG treated, S2 infected, replicate 3 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions 17-AAG treated |
| GSM4681412 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 2 , 800 nM Ganetespib treated, S2 infected, replicate 1 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions Ganetespib treated |
| GSM4681413 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 2 , 800 nM Ganetespib treated, S2 infected, replicate 2 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions Ganetespib treated |
| GSM4681414 | polyA RNA from Calu3 cells, Hsp90 Inhibitors Exp. 2 , 800 nM Ganetespib treated, S2 infected, replicate 3 | lung adenocarcinoma cell line [Calu-3 ] |
16 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions Ganetespib treated |
| GSM5022796 | polyA RNA from AEC, harvested at 24hpi, mock infected, DMSO (solvent) treated, replicate 1 | respiratory epithelium cell |
Mock | Uninfected | Data failed QC Could not download |
|
| GSM5022797 | polyA RNA from AEC, harvested at 24hpi, mock infected, DMSO (solvent) treated, replicate 2 | respiratory epithelium cell |
Mock | Uninfected | Data failed QC Could not download |
|
| GSM5022798 | polyA RNA from AEC, harvested at 24hpi, mock infected, DMSO (solvent) treated, replicate 3 | respiratory epithelium cell |
Mock | Uninfected | Data failed QC Could not download |
|
| GSM5022799 | polyA RNA from AEC, harvested at 24hpi, mock infected, 17-AAG (200 nM) treated, replicate 1 | respiratory epithelium cell |
Mock | Uninfected | Extra interventions 17-AAG treated |
|
| GSM5022800 | polyA RNA from AEC, harvested at 24hpi, mock infected, 17-AAG (200 nM) treated, replicate 2 | respiratory epithelium cell |
Mock | Uninfected | Extra interventions 17-AAG treated |
|
| GSM5022801 | polyA RNA from AEC, harvested at 24hpi, mock infected, 17-AAG (200 nM) treated, replicate 3 | respiratory epithelium cell |
Mock | Uninfected | Extra interventions 17-AAG treated |
|
| GSM5022802 | polyA RNA from AEC, harvested at 24hpi, SARS-CoV-2 infected, DMSO (solvent) treated, replicate 1 | respiratory epithelium cell |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Data failed QC Could not download |
| GSM5022803 | polyA RNA from AEC, harvested at 24hpi, SARS-CoV-2 infected, DMSO (solvent) treated, replicate 2 | respiratory epithelium cell |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Data failed QC Could not download |
| GSM5022804 | polyA RNA from AEC, harvested at 24hpi, SARS-CoV-2 infected, DMSO (solvent) treated, replicate 3 | respiratory epithelium cell |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Data failed QC Could not download |
| GSM5022805 | polyA RNA from AEC, harvested at 24hpi, SARS-CoV-2 infected, 17-AAG (200 nM) treated, replicate 1 | respiratory epithelium cell |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions 17-AAG treated |
| GSM5022806 | polyA RNA from AEC, harvested at 24hpi, SARS-CoV-2 infected, 17-AAG (200 nM) treated, replicate 2 | respiratory epithelium cell |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions 17-AAG treated |
| GSM5022807 | polyA RNA from AEC, harvested at 24hpi, SARS-CoV-2 infected, 17-AAG (200 nM) treated, replicate 3 | respiratory epithelium cell |
24 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions 17-AAG treated |
| GSM5022808 | polyA RNA from AEC, harvested at 48hpi, mock infected, DMSO (solvent) treated, replicate 1 | respiratory epithelium cell |
Mock | Uninfected | Data failed QC Could not download |
|
| GSM5022809 | polyA RNA from AEC, harvested at 48hpi, mock infected, DMSO (solvent) treated, replicate 2 | respiratory epithelium cell |
Mock | Uninfected | Data failed QC Could not download |
|
| GSM5022810 | polyA RNA from AEC, harvested at 48hpi, mock infected, DMSO (solvent) treated, replicate 3 | respiratory epithelium cell |
Mock | Uninfected | Data failed QC Could not download |
|
| GSM5022811 | polyA RNA from AEC, harvested at 48hpi, mock infected, 17-AAG (200 nM) treated, replicate 1 | respiratory epithelium cell |
Mock | Uninfected | Extra interventions 17-AAG treated |
|
| GSM5022812 | polyA RNA from AEC, harvested at 48hpi, mock infected, 17-AAG (200 nM) treated, replicate 2 | respiratory epithelium cell |
Mock | Uninfected | Extra interventions 17-AAG treated |
|
| GSM5022813 | polyA RNA from AEC, harvested at 48hpi, mock infected, 17-AAG (200 nM) treated, replicate 3 | respiratory epithelium cell |
Mock | Uninfected | Extra interventions 17-AAG treated |
|
| GSM5022814 | polyA RNA from AEC, harvested at 48hpi, SARS-CoV-2 infected, DMSO (solvent) treated, replicate 1 | respiratory epithelium cell |
48 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Data failed QC Could not download |
| GSM5022815 | polyA RNA from AEC, harvested at 48hpi, SARS-CoV-2 infected, DMSO (solvent) treated, replicate 2 | respiratory epithelium cell |
48 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Data failed QC Could not download |
| GSM5022816 | polyA RNA from AEC, harvested at 48hpi, SARS-CoV-2 infected, DMSO (solvent) treated, replicate 3 | respiratory epithelium cell |
48 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Data failed QC Could not download |
| GSM5022817 | polyA RNA from AEC, harvested at 48hpi, SARS-CoV-2 infected, 17-AAG (200 nM) treated, replicate 1 | respiratory epithelium cell |
48 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions 17-AAG treated |
| GSM5022818 | polyA RNA from AEC, harvested at 48hpi, SARS-CoV-2 infected, 17-AAG (200 nM) treated, replicate 2 | respiratory epithelium cell |
48 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions 17-AAG treated |
| GSM5022819 | polyA RNA from AEC, harvested at 48hpi, SARS-CoV-2 infected, 17-AAG (200 nM) treated, replicate 3 | respiratory epithelium cell |
48 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions 17-AAG treated |
| GSM5022820 | polyA RNA from AEC, harvested at 72hpi, mock infected, DMSO (solvent) treated, replicate 1 | respiratory epithelium cell |
Mock | Uninfected | Data failed QC Could not download |
|
| GSM5022821 | polyA RNA from AEC, harvested at 72hpi, mock infected, DMSO (solvent) treated, replicate 2 | respiratory epithelium cell |
Mock | Uninfected | Data failed QC Could not download |
|
| GSM5022822 | polyA RNA from AEC, harvested at 72hpi, mock infected, DMSO (solvent) treated, replicate 3 | respiratory epithelium cell |
Mock | Uninfected | Data failed QC Could not download |
|
| GSM5022823 | polyA RNA from AEC, harvested at 72hpi, mock infected, 17-AAG (200 nM) treated, replicate 1 | respiratory epithelium cell |
Mock | Uninfected | Extra interventions 17-AAG treated |
|
| GSM5022824 | polyA RNA from AEC, harvested at 72hpi, mock infected, 17-AAG (200 nM) treated, replicate 2 | respiratory epithelium cell |
Mock | Uninfected | Extra interventions 17-AAG treated |
|
| GSM5022825 | polyA RNA from AEC, harvested at 72hpi, mock infected, 17-AAG (200 nM) treated, replicate 3 | respiratory epithelium cell |
Mock | Uninfected | Extra interventions 17-AAG treated |
|
| GSM5022826 | polyA RNA from AEC, harvested at 72hpi, SARS-CoV-2 infected, DMSO (solvent) treated, replicate 1 | respiratory epithelium cell |
72 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Data failed QC Could not download |
| GSM5022827 | polyA RNA from AEC, harvested at 72hpi, SARS-CoV-2 infected, DMSO (solvent) treated, replicate 2 | respiratory epithelium cell |
72 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Data failed QC Could not download |
| GSM5022828 | polyA RNA from AEC, harvested at 72hpi, SARS-CoV-2 infected, DMSO (solvent) treated, replicate 3 | respiratory epithelium cell |
72 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Data failed QC Could not download |
| GSM5022829 | polyA RNA from AEC, harvested at 72hpi, SARS-CoV-2 infected, 17-AAG (200 nM) treated, replicate 1 | respiratory epithelium cell |
72 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions 17-AAG treated |
| GSM5022830 | polyA RNA from AEC, harvested at 72hpi, SARS-CoV-2 infected, 17-AAG (200 nM) treated, replicate 2 | respiratory epithelium cell |
72 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions 17-AAG treated |
| GSM5022831 | polyA RNA from AEC, harvested at 72hpi, SARS-CoV-2 infected, 17-AAG (200 nM) treated, replicate 3 | respiratory epithelium cell |
72 hrs | SARS-CoV-2 | Severe acute respiratory syndrome-related coronavirus | Extra interventions 17-AAG treated |